Clinical Neurology and Neurosurgery
Volume 112, Issue 7 , Pages 616-620 , September 2010

Nutrition in multiple sclerosis

  • Mario Habek

      Affiliations

    • School of Medicine, University of Zagreb, Department of Neurology, Zagreb, Croatia
    • University Hospital Center Zagreb, Department of Neurology, Refferal Center for Demyelinating Diseases of the Central Nervous System, Zagreb, Croatia
    • Corresponding Author InformationCorresponding author at: University Department of Neurology, Zagreb School of Medicine and University Hospital Center, Kispaticeva 12, HR-10000 Zagreb, Croatia. Tel.: +385 98883323; fax: +385 12421891.
    • ,
  • Iva Hojsak

      Affiliations

    • Children's Hospital Zagreb, Department of Pediatrics, Referral Center for Pediatric Gastroenterology and Nutrition, Zagreb, Croatia
    • ,
  • Vesna V. Brinar

      Affiliations

    • School of Medicine, University of Zagreb, Department of Neurology, Zagreb, Croatia
    • University Hospital Center Zagreb, Department of Neurology, Refferal Center for Demyelinating Diseases of the Central Nervous System, Zagreb, Croatia

Received 1 March 2010 ,Revised 28 March 2010 ,Accepted 29 March 2010.

References 

  1. Farinotti M, Simi S, Di Pietrantonj C, McDowell N, Brait L, Lupo D, et al. Dietary interventions for multiple sclerosis. Cochrane Database Syst Rev. 2007;24(January (1)):CD004192
  2. Schwartz CE, Laitin E, Brotman S, LaRocca N. Utilization of unconventional treatments by persons with MS: is it alternative or complementary?. Neurology. 1999;52:626–629
  3. Schwarz S, Leweling H. Multiple sclerosis and nutrition. Mult Scler. 2005;11:24–32
  4. Payne A. Nutrition and diet in the clinical management of multiple sclerosis. J Hum Nutr Diet. 2001;14:349–357
  5. Das UN. Is there a role for saturated and long-chain fatty acids in multiple sclerosis?. Nutrition. 2003;19:163–166
  6. Swank RL, Goodwin JW. How saturated fats may be a causative factor in multiple sclerosis and other diseases. Nutrition. 2003;19:478
  7. Antonovsky A, Leibowitz U, Smith HA. Epidemiologic study of multiple sclerosis in Israel. I. An overall review of methods and findings. Arch Neurol. 1965;13:183–193
  8. Cendrowski W, Wender M, Dominik W, Flejsierowicz Z, Owsianowski M, Popiel M. Epidemiological study of multiple sclerosis in western Poland. Eur Neurol. 1969;2:90–108
  9. Berr C, Puel J, Clanet M, Ruidavets JB, Mas JL, Alperovitch A. Risk factors in multiple sclerosis: a population-based case–control study in Hautes-Pyrenees, France. Acta Neurol Scand. 1989;80:46–50
  10. Tola MR, Granieri E, Malagu S, Caniatti L, Casetta I, Govoni V, et al. Dietary habits and multiple sclerosis. A retrospective study in Ferrara, Italy. Acta Neurol (Napoli). 1994;16:189–197
  11. Zhang SM, Willett WC, Hernan MA, Olek MJ, Ascherio A. Dietary fat in relation to risk of multiple sclerosis among two large cohorts of women. Am J Epidemiol. 2000;152:1056–1064
  12. Sepcic J, Mesaros E, Materljan E, Sepic-Grahovac D. Nutritional factors and multiple sclerosis in Gorski Kota, Croatia. Neuroepidemiology. 1993;12:234–240
  13. Isaacs EB, Fischl BR, Quinn BT, Chong WK, Gadian DG, Lucas A. Impact of breast milk on IQ, brain size and white matter development. Pediatr Res. 2010;67:357–362
  14. Pisacane A, Impagliazzo N, Russo M, Valiani R, Mandarini A, Florio C, et al. Breast feeding and multiple sclerosis. BMJ. 1994;308:1411–1412
  15. Spencely M, Dick G. Breast feeding and multiple sclerosis. Neuroepidemiology. 1982;1:216–222
  16. Brown SJ. The role of vitamin D in multiple sclerosis. Ann Pharmacother. 2006;40:1158–1161
  17. Kidd PM. Multiple sclerosis, an autoimmune inflammatory disease: prospects for its integrative management. Altern Med Rev. 2001;6:540–566
  18. Auer DP, Schumann EM, Kumpfel T, Gossl C, Trenkwalder C. Seasonal fluctuations of gadolinium-enhancing magnetic resonance imaging lesions in multiple sclerosis. Ann Neurol. 2000;47:276–277
  19. Hayes CE. Vitamin, D: a natural inhibitor of multiple sclerosis. Proc Nutr Soc. 2000;59(4):531–535
  20. Eyles D, Almeras L, Benech P, Patatian A, Mackay-Sim A, McGrath J, et al. Developmental vitamin D deficiency alters the expression of genes encoding mitochondrial, cytoskeletal and synaptic proteins in the adult rat brain. J Steroid Biochem Mol Biol. 2007;103:538–545
  21. Cantorna MT. Vitamin D and multiple sclerosis: an update. Nutr Rev. 2008;66:S135–S138
  22. Munger KL, Levin LI, Hollis BW, Howard NS, Ascherio A. Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis. JAMA. 2006;296:2832–2838
  23. Koch MW, Ramsaransing GS, Arutjunyan AV, Stepanov M, Teelken A, Heersema DJ, et al. Oxidative stress in serum and peripheral blood leukocytes in patients with different disease courses of multiple sclerosis. J Neurol. 2006;253:483–487
  24. Ferretti G, Bacchetti T, Principi F, Di Ludovico F, Viti B, Angeleri VA, et al. Increased levels of lipid hydroperoxides in plasma of patients with multiple sclerosis: a relationship with paraoxonase activity. Mult Scler. 2005;11:677–682
  25. Gilgun-Sherki Y, Melamed E, Offen D. The role of oxidative stress in the pathogenesis of multiple sclerosis: the need for effective antioxidant therapy. J Neurol. 2004;251:261–268
  26. Butcher J. The distribution of multiple sclerosis in relation to the dairy industry and milk consumption. N Z Med J. 1976;83:427–430
  27. Ramagopalan SV, Dyment DA, Guimond C, Orton SM, Yee IM, Ebers GC, et al. Childhood cow's milk allergy and the risk of multiple sclerosis: Aa population based study. J Neurol Sci. 2010;291:86–88
  28. Shor DB, Barzilai O, Ram M, Izhaky D, Porat-Katz BS, Chapman J, et al. Gluten sensitivity in multiple sclerosis: experimental myth or clinical truth?. Ann NY Acad Sci. 2009;1173:343–349
  29. Reichelt KL, Jensen D. IgA antibodies against gliadin and gluten in multiple sclerosis. Acta Neurol Scand. 2004;110:239–241
  30. Borhani Haghighi A, Ansari N, Mokhtari M, Geramizadeh B, Lankarani KB. Multiple sclerosis and gluten sensitivity. Clin Neurol Neurosurg. 2007;109:651–653
  31. Pasquinelli S, Solaro C. Nutritional assessment and malnutrition in multiple sclerosis. Neurol Sci. 2008;29:S367–S369
  32. Pennington CR. Disease and malnutrition in British hospitals. Proc Nutr Soc. 1997;6:393–407
  33. Kamalian N, Keesey RE, ZuRhein GM. Lateral hypothalamic demyelination and cachexia in a case of ‘malignant’ multiple sclerosis. Neurology. 1975;25:25–30
  34. Fantelli FJ, Mitsumoto H, Sebek BA. Multiple sclerosis and malabsorption. Lancet. 1978;1:1039–1040
  35. Williams CM, Lines CM, McKay EC. Iron and zinc status in multiple sclerosis patients with pressure sores. Eur J Clin Nutr. 1988;42:321–328
  36. Wozniak-Wowk CS. Nutrition intervention in the management of multiple sclerosis. Nutr Today. 1993;28:12–20
  37. Slawta JN, Wilcox AR, McCubbin JA, Nalle DJ, Fox SD, Anderson G. Health behaviors, body composition, and coronary heart disease risk in women with multiple sclerosis. Arch Phys Med Rehabil. 2003;84:1823–1830
  38. Timmerman GM, Stuifbergen AK. Eating patterns in women with multiple sclerosis. Neurosci Nurs. 1999;31:152–158
  39. Hewson DC, Phillips MA, Simpson KE, Drury P, Crawford MA. Food intake in multiple sclerosis. Hum Nutr Appl Nutr. 1984;38:355–367
  40. Khurana SR, Bamer AM, Turner AP, Wadhwani RV, Bowen JD, Leipertz SL, et al. The prevalence of overweight and obesity in veterans with multiple sclerosis. Am J Phys Med Rehabil. 2009;88:83–91
  41. Hunt DR, Maslovitz A, Rowlands BJ, Brooks B. A simple nutrition screening procedure for hospital patients. J Am Diet Assoc. 1985;85:332–335
  42. Detsky AS, McLaughlin JR, Baker JP, Johnston N, Whittaker S, Mendelson RA, et al. What is subjective global assessment of nutritional status?. J Parenter Enteral Nutr. 1987;11:8
  43. Rubenstein LZ, Harker JO, Salva‘ A, Guigoz Y, Vellas B. Screening for undernutrition in geriatric practice: developing the short-form mininutritional assessment (MNA-SF). J Gerontol A Biol Sci Med Sci. 2001;56:366–372
  44. British Association for Enteral and Parenteral Nutrition (BAPEN). The ‘MUST’ explanatory booklet. A guide to ‘Malnutrition Universal Screening Tool’ (‘MUST’) for adults; November 2003. Available at: http://www.bapen.org.uk/pdfs/must/must_explan.pdf) [accessed July 15, 2008].
  45. Kondrup J, Allison SP, Elia M, Vellas B, Plauth M Educational and Clinical Practice Committee. European Society for Parenteral and Enteral Nutrition (ESPEN). ESPEN guidelines for nutrition screening 2002. Clin Nutr. 2003;22:415–421
  46. Correia MITD, Waltzberg DL. The impact of malnutrition on morbidity, mortality, length of hospital stay and costs evaluated through a multivariate model analysis. Nutrition. 2003;22:235–239
  47. Carney DE, Meguid MM. Current concepts in nutritional assessment. Arch Surg. 2002;137(January (1)):42–45
  48. Maqbool A, Olsen IE, Stallings VA. Clinical assessment of nutritional status. In:  Duggan C,  Watkins JB,  Walker WA editor. Nutrition in pediatrics. 4th ed.. Hamilton: BC Decker Inc.; 2008;p. 5–13
  49. Zemel BS, Riley EM, Stallings VA. Evaluation of methodology for nutritional assessment in children: anthropometry, body composition, and energy expenditure. Annu Rev Nutr. 1997;17:211–235
  50. DeLegge MH, Drake LM. Nutritional assessment. Gastroenterol Clin North Am. 2007;36:1–22
  51. Morgan DB, Hill GL, Baker JP. The assessment of weight loss from a single measurement of body weight: problems and limitations. Am J Clin Nutr. 1980;33:2101–2110
  52. Blackburn GL, Bistrian BR, Maini BS, Schlamm HT, Smith MF. Nutritional and metabolic assessment of the hospitalized patient. JPEN J Parenter Enteral Nutr. 1977;1:11–22
  53. Carney DE, Meguid MM. Current concepts in nutritional assessment. Arch Surg. 2002;137:42–45
  54. Jeejeebhoy KN. Nutritional assessment. Nutrition. 2000;16(July–August (7–8)):585–590
  55. Evans-Stoner N. Nutrition assessment: a practical approach. Nurs Clin North Am. 1997;32:637–651
  56. Bailey J. Healthy eating: a guide for people with MS; 2008 [available at: http://www.mssociety.ca/en/pdf/eating.pdf].
  57. Shinto L, Calabrese C, Morris C, Sinsheimer S, Bourdette D. Complementary and alternative medicine in multiple sclerosis: survey of licensed naturopaths. J Altern Complement Med. 2004;10:891–897
  58. Millar JH, Zilkha KJ, Langman MJ, Wright HP, Smith AD, Belin J, et al. Double-blind trial of linoleate supplementation of the diet in multiple sclerosis. Br Med J. 1973;1:765–768
  59. Bates D, Fawcett PR, Shaw DA, Weightman D. Trail of polyunsaturated fatty acids in non-relapsing multiple sclerosis. Br Med J. 1977;2:932–933
  60. Bates D, Fawcett PR, Shaw DA, Weightman D. Polyunsaturated fatty acids in treatment of acute remitting multiple sclerosis. Br Med J. 1978;2:1390–1391
  61. Bates D, Cartlidge NE, French JM, Jackson MJ, Nightingale S, Shaw DA, et al. A double-blind controlled trial of long chain n-3 polyunsaturated fatty acids in the treatment of multiple sclerosis. J Neurol Neurosurg Psychiatry. 1989;52:18–22
  62. Weinstock-Guttman B, Baier M, Park Y, Feichter J, Lee-Kwen P, Gallagher E, et al. Low fat dietary intervention with omega-3 fatty acid supplementation in multiple sclerosis patients. Prostaglandins Leukot Essent Fatty Acids. 2005;73:397–404
  63. Cantorna MT, Hayes CE, DeLuca HF. 1,25-Dihydroxyvitamin D3 reversibly blocks the progression of relapsing encephalomyelitis, a model of multiple sclerosis. Proc Natl Acad Sci USA. 1996;93:7861–7864
  64. Spach KM, Pedersen LB, Nashold FE, Kayo T, Yandell BS, Prolla TA, et al. Gene expression analysis suggests that 1,25- dihydroxyvitamin D3 reverses experimental autoimmune encephalomyelitis by stimulating inflammatory cell apoptosis. Physiol Genomics. 2004;18:141–151
  65. Goldberg P, Fleming MC, Picard EH. Multiple sclerosis: decreased relapse rate through dietary supplementation with calcium, magnesium and vitamin D. Med Hypotheses. 1986;21:193–200
  66. Wingerchuk DM, Lesaux J, Rice GP, Kremenchutzky M, Ebers GC. A pilot study of oral calcitriol (1,25-dihydroxyvitamin D3) for relapsing-remitting multiple sclerosis. J Neurol Neurosurg Psychiatry. 2005;76:1294–1296
  67. Wade DT, Young CA, Chaudhuri KR, Davidson DL. A randomised placebo controlled exploratory study of vitamin B-12, lofepramine, and l-phenylalanine (the “Cari Loder regime”) in the treatment of multiple sclerosis. J Neurol Neurosurg Psychiatry. 2002;73:246–249
  68. Kira J, Tobimatsu S, Goto I. Vitamin B12 metabolism and massive-dose methyl vitamin B12 therapy in Japanese patients with multiple sclerosis. Intern Med. 1994;33:82–86

PII: S0303-8467(10)00102-2

doi: 10.1016/j.clineuro.2010.03.029

Clinical Neurology and Neurosurgery
Volume 112, Issue 7 , Pages 616-620 , September 2010

Article Tools